These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25072257)

  • 21. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stathmin1 overexpression in hypopharyngeal squamous cell carcinoma: A new promoter in FaDu cell proliferation and migration.
    Chen Y; Zhang Q; Ding C; Zhang X; Qiu X; Zhang Z
    Int J Oncol; 2017 Jan; 50(1):31-40. PubMed ID: 27878293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multivariate analysis of recurrence and progression in stage T1 transitional-cell carcinoma of the bladder. Prognostic value of p53 and Ki67].
    Rodríguez Alonso A; Pita Fernández S; González-Carreró J; Nogueira March JL
    Actas Urol Esp; 2003 Feb; 27(2):132-41. PubMed ID: 12731328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STMN1 in colon cancer: expression and prognosis in Chinese patients.
    Zhang HQ; Guo X; Guo SQ; Wang Q; Chen XQ; Li XN; Guo LS
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2038-44. PubMed ID: 27249602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer.
    Suzuki K; Watanabe A; Araki K; Yokobori T; Harimoto N; Gantumur D; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Kubo N; Gombodorj N; Nishiyama M; Hosouchi Y; Kuwano H; Shirabe K
    Anticancer Res; 2018 Feb; 38(2):939-944. PubMed ID: 29374725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement.
    Frank I; Cheville JC; Blute ML; Lohse CM; Karnes RJ; Weaver AL; Sebo TJ; Nehra A; Zincke H
    Cancer; 2004 Oct; 101(8):1803-8. PubMed ID: 15386300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reply to the letter: "In reference to the article: Multivariate analysis of recurrence and progression of stage T1 transitional cell carcinoma of the bladder. Prognostic value of p53 and kI67].
    Rodríguez Alonso A; Pita Fernández S
    Actas Urol Esp; 2003 Oct; 27(9):746-7. PubMed ID: 14626689
    [No Abstract]   [Full Text] [Related]  

  • 29. Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.
    Franco R; Zappavigna S; Gigantino V; Luce A; Cantile M; Cerrone M; Facchini G; Perdonà S; Pignata S; Di Lorenzo G; Chieffi S; Vitale G; De Sio M; Sgambato A; Botti G; Yousif AM; Novellino E; Grieco P; Caraglia M
    J Exp Clin Cancer Res; 2014 Jun; 33(1):48. PubMed ID: 24893613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.
    Yin H; Qin C; Zhao Y; Du Y; Sheng Z; Wang Q; Song Q; Chen L; Liu C; Xu T
    Clin Transl Oncol; 2017 Aug; 19(8):1035-1044. PubMed ID: 28258492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of MCM2 immunoreactivity in stage T1 transitional cell carcinoma of the bladder.
    Krüger S; Thorns C; Stöcker W; Müller-Kunert E; Böhle A; Feller AC
    Eur Urol; 2003 Feb; 43(2):138-45. PubMed ID: 12565771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
    Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
    Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
    Boman K; Segersten U; Ahlgren G; Eberhard J; Uhlén M; Jirström K; Malmström PU
    BMC Urol; 2013 Apr; 13():17. PubMed ID: 23565664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unbiased proteomic and transcript analyses reveal that stathmin-1 silencing inhibits colorectal cancer metastasis and sensitizes to 5-fluorouracil treatment.
    Wu W; Tan XF; Tan HT; Lim TK; Chung MC
    Mol Cancer Res; 2014 Dec; 12(12):1717-28. PubMed ID: 25063586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.
    Bai T; Yokobori T; Altan B; Ide M; Mochiki E; Yanai M; Kimura A; Kogure N; Yanoma T; Suzuki M; Bao P; Kaira K; Asao T; Katayama A; Handa T; Gombodorj N; Nishiyama M; Oyama T; Ogata K; Kuwano H
    Br J Cancer; 2017 Apr; 116(9):1177-1185. PubMed ID: 28334732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers.
    Liu J; Li J; Wang K; Liu H; Sun J; Zhao X; Yu Y; Qiao Y; Wu Y; Zhang X; Zhang R; Yang A
    Signal Transduct Target Ther; 2021 Feb; 6(1):42. PubMed ID: 33526768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
    Xue Y; Wu G; Wang X; Zou X; Zhang G; Xiao R; Yuan Y; Long D; Yang J; Wu Y; Xu H; Liu F; Liu M
    Med Oncol; 2013 Mar; 30(1):406. PubMed ID: 23275123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.
    Gontero P; Casetta G; Zitella A; Ballario R; Pacchioni D; Magnani C; Muir GH; Tizzani A
    Eur Urol; 2000 Sep; 38(3):287-96. PubMed ID: 10940702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.
    Obayashi S; Horiguchi J; Higuchi T; Katayama A; Handa T; Altan B; Bai T; Bao P; Bao H; Yokobori T; Nishiyama M; Oyama T; Kuwano H
    Int J Oncol; 2017 Sep; 51(3):781-790. PubMed ID: 28766688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.
    Ogino S; Nosho K; Baba Y; Kure S; Shima K; Irahara N; Toyoda S; Chen L; Kirkner GJ; Wolpin BM; Chan AT; Giovannucci EL; Fuchs CS
    Am J Gastroenterol; 2009 Aug; 104(8):2047-56. PubMed ID: 19513025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.